Results 121 to 130 of about 104,379 (168)

Correction: ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management. [PDF]

BMC Med Inform Decis Mak
Mouazer A, Léguillon R, Boudegzdame N, Levrard T, Le Bars Y, Simon C, Séroussi B, Grosjean J, Lelong R, Letord C, Darmoni S, Schuers M, Belmin J, Sedki K, Dubois S, Falcoff H, Tsopra R, Lamy JB.   +17 more
europepmc   +1 more source

[Predictive factors of response to biotherapies in patients with rheumatoid arthritis: a cross-sectional observational study conducted in the Rheumatology Department of the Mohammed V Military Teaching Hospital, Rabat (Morocco)]. [PDF]

Pan Afr Med J
Sagara M, Majjad A, Toufik H, Bezza A.
europepmc   +1 more source

[Idiopathic granulomatous mastitis: report of 10 cases]. [PDF]

Pan Afr Med J
Ndong VS, Taki G, Harmouche H.
europepmc   +1 more source

[Factors associated with mothers' first therapeutic recourse for children aged 0-5 years in Benin]. [PDF]

Pan Afr Med J
Atiogbe KG, Gaffan N, Aviansou AS, Sopoh GE, Ouendo EM.   +4 more
europepmc   +1 more source

Heart-Lung transplantation: Meeting allocation challenges in France. [PDF]

JHLT Open
Issard J, Merveilleux du Vignaux C, Renard S, Lepoivre T, Mertes PM, Dorent R, Epailly E, Hascoet S, Olland A, Le Pavec J, Fadel E, Savale L, Mercier O.   +12 more
europepmc   +1 more source

Editorial: Surgical approaches and outcomes in cervical and thoracic myelopathies. [PDF]

Front Surg
Ayache SS, Abi Lahoud GN, Chalah MA.
europepmc   +1 more source

[Castleman disease with systemic manifestation: a case report]. [PDF]

Pan Afr Med J
Hmimsa A, Touihem N, Attifi H, Hmidi M.
europepmc   +1 more source

[<i>Mycobacterium tuberculosis</i> cerebral vasculitis: a pediatric case report]. [PDF]

Pan Afr Med J
Bossoma GA, N'guessan YCB, Kouadio JMK.
europepmc   +1 more source

[Desmoplastic fibroma of bone: a case report]. [PDF]

Pan Afr Med J
Doublali L, Adnani A, Belhouari M, Bourhafour M, Sahraoui S.   +4 more
europepmc   +1 more source

Daratumumab in relapse-refractory immune-mediated thrombotic thrombocytopenic purpura: additional evidence for its efficacy. [PDF]

Res Pract Thromb Haemost
Coppo P.
europepmc   +1 more source